NicVax: Completed Phase III enrollment

Nabi completed enrollment of about 1,000 patients in a double-blind, placebo-controlled Phase III trial. This is the first of 2 ongoing Phase III studies for which Nabi has an SPA from FDA. GlaxoSmit...